GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Glow LifeTech Corp (XCNQ:GLOW) » Definitions » EBITDA Margin %

Glow LifeTech (XCNQ:GLOW) EBITDA Margin % : -1,589.47% (As of Sep. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Glow LifeTech EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Glow LifeTech's EBITDA for the three months ended in Sep. 2023 was C$-0.30 Mil. Glow LifeTech's Revenue for the three months ended in Sep. 2023 was C$0.02 Mil. Therefore, Glow LifeTech's EBITDA margin for the quarter that ended in Sep. 2023 was -1,589.47%.


Glow LifeTech EBITDA Margin % Historical Data

The historical data trend for Glow LifeTech's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Glow LifeTech EBITDA Margin % Chart

Glow LifeTech Annual Data
Trend Dec19 Dec20 Dec21 Dec22
EBITDA Margin %
- - - -

Glow LifeTech Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -1,589.47

Competitive Comparison of Glow LifeTech's EBITDA Margin %

For the Biotechnology subindustry, Glow LifeTech's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Glow LifeTech's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Glow LifeTech's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Glow LifeTech's EBITDA Margin % falls into.



Glow LifeTech EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Glow LifeTech's EBITDA Margin % for the fiscal year that ended in Dec. 2022 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=-1.679/0
= %

Glow LifeTech's EBITDA Margin % for the quarter that ended in Sep. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2023 )/Revenue (Q: Sep. 2023 )
=-0.302/0.019
=-1,589.47 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Glow LifeTech  (XCNQ:GLOW) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Glow LifeTech EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Glow LifeTech's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Glow LifeTech (XCNQ:GLOW) Business Description

Traded in Other Exchanges
Address
65 International Boulevard, Suite 206, Etobicoke, ON, CAN, M9W 6L9
Glow LifeTech Corp is a biotechnology company focused on producing nutraceutical and cannabinoid-based products with dramatically enhanced bioavailability, absorption, and effectiveness. Its plant-based MyCell Technology delivery system transforms poorly absorbed natural compounds into enhanced water-compatible concentrates, unlocking the full healing potential of natural active compounds.
Executives
Daniel Proska Director

Glow LifeTech (XCNQ:GLOW) Headlines

No Headlines